Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.
Press releases published on September 5, 2025
St. Petersburg Funeral Home & Memorial Chapel Expands Comprehensive End-of-Life Services Throughout Pinellas County
EIN Presswire
·
September 5, 2025
Local funeral home introduces new cremation facilities, memorial services, and bereavement counseling to support families during difficult times. NORTH EASTON, MA, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- Family-Owned Funeral Home …
Allen Business Advisors Announces Speaking and Exhibit Schedule for September and October
EIN Presswire
·
September 5, 2025
Silver Tsunami of Retirements? Allen Business Advisors Leads with Employee Ownership Solutions #SuccessionPlanning #Engineering BOSTON, MA, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- Allen Business Advisors, a national leader in succession …
Phrase Named a Leader by Independent Analyst Firm
EIN Presswire
·
September 5, 2025
The success of its strategy shows in its growth, retention, partnerships and the trend for other vendors in this space BOSTON, MA, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- Phrase, a leading AI-first language technology platform, today …
VoDaVi Technologies Awarded New 5-Year MHEC Contract for Network Infrastructure and Management
EIN Presswire
·
September 5, 2025
VoDaVi Technologies has been awarded a new 5-year contract under the MHEC MC02-F14 for Network Infrastructure …
DIH Holding US, Inc. Receives Nasdaq Staff Determination Letter
GlobeNewswire
·
September 5, 2025
DIH Receives Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market DIH Intends to Request Hearing to Appeal in a Timely Manner NORWELL, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ …
Spyre Therapeutics Announces Grants of Inducement Awards
GlobeNewswire
·
September 5, 2025
WALTHAM, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic …
Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025
GlobeNewswire
·
September 5, 2025
BOSTON and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Boiler Installation in Stoneham, MA, Redefined by Presidential Heating & Plumbing
EIN Presswire
·
September 5, 2025
Presidential Heating …
Avania renforce son équipe de direction avec la nomination de quatre nouveaux dirigeants
GlobeNewswire
·
September 5, 2025
BILTHOVEN, Pays-Bas et BOSTON, 05 sept. 2025 (GLOBE NEWSWIRE) -- Avania, le leader mondial du conseil et du développement clinique dans le secteur de la MedTech, a le plaisir d’annoncer la nomination stratégique de quatre dirigeants éminents. Alors que le …
Avania verstärkt Führungsteam mit der Ernennung von vier neuen Führungskräften
GlobeNewswire
·
September 5, 2025
BILTHOVEN, Niederlande und BOSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Avania, der weltweit führende Partner für Medizintechnikberatung und klinische Entwicklung, freut sich, die Ernennung von vier angesehenen Führungskräften in strategische …
메드테크 자문기업인 Avania, 4명의 신규 임원 임명으로 리더십 팀 강화
GlobeNewswire
·
September 5, 2025
네덜란드 빌트호벤 및 보스턴, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 선도적인 메드테크(MedTech) 자문 서비스와 임상 개발 파트너인 Avania가 4명의 저명한 임원을 전략적 리더십 자리에 임명한다고 발표했다. 메드테크 산업이 점점 복잡해지는 규제 환경과 기술 혁신을 헤쳐 나가는 가운데, 이번에 선임된 신규 임원들은 임상 연구, 규제 업무, 운영, 정보기술, 사업 개발 분야에서 수십 년에 걸친 경험을 결합해 Avania의 …
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
GlobeNewswire
·
September 5, 2025
~ All patients in the first cohort achieved between 27- to 208-fold increases in α-Gal A activity relative to mean normal level ~ ~ All patients in first cohort discontinued enzyme replacement therapy ~ ~ Preliminary data show AMT-191 has a manageable …
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
GlobeNewswire
·
September 5, 2025
-- The 2025 DREAMS Grant Program awards $50,000 each to two non-profit organizations working to advance equity, accessibility and inclusion for those living with Duchenne in the U.S., EU or U.K. -- -- Announced in advance of World Duchenne Awareness Day on …
AAVantgarde presents updated positive clinical data from its AAVB-081 program for Usher 1B at EURetina 2025
GlobeNewswire
·
September 5, 2025
MILAN, Sept. 05, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated clinical data from the …
Akari Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 5, 2025
BOSTON and LONDON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that Abizer Gaslightwala, President and Chief …
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
BEDFORD, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on September …